Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 466 of 6351
-
Engineered immune cells take on aggressive MS in early trial
Disease control Recruiting nowThe goal of this trial is to assess the feasibility, safety and preliminary efficacy of MB-CART2019.1 in patients with active refractory primary and secondary progressive MS.
Phase 1/2 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New combo therapy aims to make inoperable liver cancer removable
Disease control Recruiting nowHepatocellular carcinoma (HCC) is a major cause of cancer-related deaths globally, with Native Hawaiian and Pacific Islander (NHPI) populations experiencing significantly higher mortality rates compared to other groups in Hawaii. This disparity is influenced by factors such as hi…
Phase 1 • Sponsor: University of Hawaii • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Booster shot may extend time between surgeries for RRP patients
Disease control Not yet recruitingThe investigators propose the study titled "Efficacy of booster injection with Gardasil-9 vaccine on intersurgical interval (ISI) for adults with recurrent respiratory papillomatosis (RRP)". Recurrent respiratory papillomatosis (RRP) is a human papilloma virus (HPV) mediated dis…
Phase 1/2 • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New study tests if diet and exercise can replace blood pressure pills
Disease control Not yet recruitingThe REMIDEP-HTA trial is a multicenter randomized controlled study designed to evaluate whether a structured approach combining an intensive lifestyle intervention with a systematic deprescribing algorithm can achieve clinical remission of essential hypertension. \<br\>\<br\> T…
Sponsor: Evelyn Vanina Re • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Spinal injury breakthrough: brain zaps may restore grip
Symptom relief Recruiting nowThe goal of this study is to restore the activities of late descending signals with a noninvasive stimulation approach in combination with hand motor training to improve hand function in persons with cervical SCI. The main question it aims to answer is if the inputs to late desce…
Sponsor: State University of New York at Buffalo • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Light therapy vs. vitamin d cream: new hope for oral cancer prevention?
Disease control Not yet recruiting(i)Rationale/ gaps in existing knowledge,: Oral cancer, one of the top three common cancers in India is usually preceded by Oral potentially malignant disorders in nearly two thirds of the cases like Oral leukoplakia. OL has a high prevalence and malignant transformation rates(0.…
Phase 3 • Sponsor: Dr. Shalini Gupta • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Brain injection method could revolutionize meningitis treatment
Disease control Not yet recruitingMultiple preclinical and clinical studies, including the investigators' published work and the ongoing SOLUTION series, have consistently demonstrated that intracalvariosseous (ICO) injection can markedly increase drug exposure within the central nervous system with acceptable sa…
Sponsor: yilong Wang • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
AI eye on X-Rays: could a computer save lives in the ER?
Diagnosis Not yet recruitingBackground Advancements in artificial intelligence (AI) have driven significant breakthroughs in computer-aided detection (CAD) for chest X-ray imaging. National Taiwan University Hospital (NTUH) research team previously developed an AI-based emergency Capstone CXR system (MOST 1…
Sponsor: National Taiwan University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Gut bacteria boost? probiotic added to chemo in breast cancer trial
Disease control Recruiting nowTo evaluate the efficacy and safety of compound preparation Biolosion in combination with standard neoadjuvant therapy for locally advanced triple-negative breast cancer
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for liver cancer patients when immunotherapy stops working
Disease control Not yet recruitingThe goal of this clinical trial is to learn if lenvatinib or regorafenib can help treat people with advanced liver cancer (hepatocellular carcinoma, HCC) that cannot be removed with surgery after first treatment with immunotherapy-based drug combinations. It will also look at the…
Phase 2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Poop pills join the fight against advanced colon cancer
Disease control Not yet recruitingThis clinical trial evaluates the efficacy and safety of adding fecal microbiota transplantation (FMT) to first-line standard of care for patients with initially unresectable colorectal cancer (CRC). FMT is an established procedure designed to restore intestinal microbiome homeo…
Phase 2/3 • Sponsor: Shanghai 10th People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New combo therapy aims to save kidneys in High-Risk cancer patients
Disease control Not yet recruitingUTUC is a cancer that develops in the lining of the kidney or ureter. The standard treatment is radical nephroureterectomy, which removes the kidney and ureter. Although this surgery can control the cancer, it permanently reduces kidney function. Endoscopic treatment can serve a…
Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for stroke survivors: can a tiny tube in the brain prevent another attack?
Disease control Not yet recruitingA multicenter, randomized, open-label, endpoint-blinded trial to compare the effects of endovascular recanalization plus aggressive medical management with aggressive medical management alone on stroke recurrence and mortality in patients with symptomatic non-acute intracranial a…
Sponsor: Feng Gao • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for tough breast cancer: Two-Drug combo tested
Disease control Recruiting nowThis study is looking at a new combination of two drugs-eribulin and anlotinib-for patients with HER2-negative advanced breast cancer. Participants in this study have already tried other treatments like T-DXd or SG, but their cancer has gotten worse, and there are currently no st…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could a tongue swab replace sputum tests for TB?
Diagnosis Not yet recruitingTuberculosis (TB) remains the leading cause of death from a single infectious agent globally, with millions of people still undiagnosed or diagnosed late. Conventional case-finding strategies rely heavily on symptom screening using the WHO Four-Symptom Screen ((W4SS; comprising a…
Sponsor: Liverpool School of Tropical Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
New drug duo aims to fight rare melanoma before surgery
Disease control Not yet recruitingThis study aims to investigate the efficacy and safety of SHR-1701 in combination with famitinib in the perioperative treatment of mucosal melanoma
Phase 2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
AI could spot mouth cancer early from a simple photo
Diagnosis Not yet recruitingSquamous cell carcinomas of the upper aerodigestive tract are among the most common cancers worldwide, with the oral cavity being the most frequent site. Oral cavity squamous cell carcinomas (OCSCC) represent a major cause of morbidity and mortality, mainly due to high rates of l…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
New lupus drug trial aims to tame the immune system
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of SCTC21C in participants with systemic lupus erythematosus
Phase 1/2 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New triple therapy hopes to outsmart tough esophageal cancer
Disease control Not yet recruitingEsophageal squamous cell carcinoma (ESCC) is a common malignant tumor worldwide, with particularly high incidence in East Asian regions such as China, and is associated with poor patient prognosis. In recent years, immune checkpoint inhibitors (e.g., anti-PD-1/PD-L1 antibodies) c…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Triple threat: new combo aims to tackle tough pancreatic cancer
Disease control Recruiting nowThis study aims to evaluate the safety and preliminary efficacy of NALIRIFOX combined with adebrelimab and PULSAR as first-line treatment for locally advanced unresectable or metastatic pancreatic ductal adenocarcinoma (PDAC). Additionally, it will explore potential predictive an…
Phase 1/2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC